NCT00211432View on ClinicalTrials.gov

Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Pseudovitellium DetachmentEye Diseases
Interventions
DRUG

Anecortave Acetate Sterile Suspension (15 mg)

Trial Locations (1)

10021

Manhattan Eye, Ear & Throat Hospital, New York

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Manhattan Eye, Ear & Throat Hospital

OTHER